Clinical Trial Update: Hybrid Immunotherapy for Hemophagocytic LymphoHistiocytosis [Phase 2]

View source ↗

Summary

A Phase 2 trial update on hybrid immunotherapy for Hemophagocytic Lymphohistiocytosis (HLH) has completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophagocytic Lymphohistiocytosis

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Hemophagocytic Lymphohistiocytosis | Phase 2 | Status: COMPLETED | Results posted: 2020-10-19